Secondary-market transactions in recent months have implied that Elon Musk’s brain‑computer interface company, Neuralink, could be worth as much as $42 billion — a steep rise from the roughly $9 billion valuation reported after its last financing. The surge, reflected in private trading and bid activity, highlights intense appetite among private investors for stakes in Musk’s remaining startups following SpaceX’s public listing.
How secondary markets are driving the spike
Because Neuralink remains privately held, there is no continuous public price discovery. Instead, employees and early investors sell shares on secondary markets, and those occasional trades are what feed valuation estimates. Private markets data provider Caplight told Business Insider that recent transactions have spanned about $29 billion to $42 billion, and that some interested buyers have bid at valuations approaching $60 billion.
These headline numbers are estimates tied to the demand for available lots, not a definitive company price set in a public market. Still, participants say the willingness of buyers to pay substantial premiums is notable: one venture investor reported limited partners asking to buy Neuralink shares “at any price.”
What Neuralink is developing — and how far it has progressed
Neuralink designs implants intended to let people with paralysis control computers through neural signals and ultimately to restore aspects of vision. The company has said it implanted its chips in 21 trial participants so far, a figure it announced earlier this year that indicates the program is still in early clinical stages.
Despite the technical ambition, Neuralink’s commercial timelines remain long and uncertain. Clinical testing, regulatory review, and the engineering challenges of scaling implantable devices mean that the path from early trials to broad clinical use is complex and time consuming.
Why investors are paying premiums for Musk-linked startups
Investors’ eagerness for Neuralink shares appears tied to broader enthusiasm for companies linked to Musk. After SpaceX’s recent IPO and its subsequent market value of about $1.6 trillion, private investors have shown a greater willingness to pay steep premiums for exposure to other firms in Musk’s portfolio.
There is also precedent for Musk’s businesses being combined or restructured in ways that created value for earlier shareholders. Investors in firms such as X and XAI later gained access to SpaceX shares through corporate moves, which has encouraged some backers to chase stakes in other Musk ventures in hopes of similar outcomes.
Recent funding and outside investors
Neuralink’s most recently announced outside investment came in May, when Oman’s sovereign wealth fund said it had invested in the company. The terms and valuation of that injection were not disclosed. The startup’s last publicly reported funding round, according to Semafor, valued the company at approximately $9 billion.
Because current valuations are derived from intermittent private trades and bids, the company has not announced an official valuation nor confirmed a new primary fundraising round tied to these secondary prices.
Risks and questions that temper enthusiasm
Despite robust secondary-market demand, not all investors are comfortable with the elevated implied prices. Some market participants balk at paying the premiums implicit in the highest recent bids, citing the experimental nature of Neuralink’s product and the significant regulatory and technical hurdles that remain.
Secondary-market valuations can be highly sensitive to sentiment and the identity of potential buyers. Offers from well‑capitalized strategic investors or prominent backers can push quoted values higher, even when the underlying business fundamentals have not materially changed.
What to watch next
Observers will be watching for any official fundraising by Neuralink that could reprice the company in a more formal way, and for updates on its clinical program that could shift perceptions of near‑term commercial potential. Further secondary trades will also shape the narrative: continued high bids would reinforce the impression of strong investor interest, while retreating prices would suggest more measured sentiment.
For now, the elevated private valuations reflect both a bet on the long‑term possibility of neural‑interface technologies and the market dynamics that come with owning a stake in one of Musk’s high‑profile ventures.
Source: Business Insider